Table 2:

Description of patients who had arrhythmias and their subsequent treatments

PatientAge, sexOngoing painECGEventIntervention
133, MYesAbnormal, not ischemicAtrial fibrillationDiltiazem intravenously
268, FNoAbnormal, not ischemicAtrial fibrillationMagnesium sulfate intravenously, atenolol orally
367, FYesIschemicAtrial fibrillationElectrical cardioversion
468, MYesPacedVentricular tachycardiaAmiodarone intravenously
551, MNoAbnormal, not ischemicAtrial fibrillationProcainamide intravenously, electrical cardioversion
671, FNoAbnormal, not ischemicAtrial flutterMetoprolol intravenously
756, MYesAbnormal, not ischemicAtrial flutterDiltiazem intravenously
858, FNoAbnormal, not ischemicSupraventricular tachycardiaDiltiazem intravenously
973, FNoAbnormal, not ischemicAtrial fibrillationProcainamide intravenously
1079, MYesAbnormal, not ischemicAtrial fibrillationDigoxin, electrical cardioversion
1167, FYesAbnormal, not ischemicAtrial fibrillationMagnesium sulfate and diltiazem intravenously
1285, MNoAbnormal, not ischemicAtrial fibrillationMetoprolol intravenously
1380, FNoAbnormal, not ischemicAtrial fibrillationDiltiazem intravenously, electrical cardioversion
1467, MNoAbnormal, not ischemicSupraventricular tachycardiaAdenosine and metoprolol intravenously
1579, FNoAbnormal, not ischemicAtrial fibrillationMetoprolol intravenously
  • Note: F = female, M = male.